<?xml version="1.0" encoding="UTF-8"?>
<p id="p0350">
 <list list-type="simple" id="olist0020">
  <list-item id="o0080">
   <label>1.</label>
   <p id="p0355">Raise the profile of viral hepatitis elimination and build political commitment through global, regional, national and local forums that engage affected communities, healthcare professionals and the broader community.</p>
  </list-item>
  <list-item id="o0085">
   <label>2.</label>
   <p id="p0360">Invest in activities to reduce stigma and discrimination against people living with hepatitis B infection, including education campaigns, law and policy change to ensure equitable healthcare access and mandate protection of the rights of people living with viral hepatitis</p>
  </list-item>
  <list-item id="o0090">
   <label>3.</label>
   <p id="p0365">Build the local investment case for elimination that delivers achievable country-specific targets through prioritising strategic action and optimal resource allocation; embed these within universal health coverage.</p>
  </list-item>
  <list-item id="o0095">
   <label>4.</label>
   <p id="p0370">Scale-up hepatitis B vaccination coverage, including birth dose delivery embedded within existing SDG-related programmes</p>
  </list-item>
  <list-item id="o0100">
   <label>5.</label>
   <p id="p0375">Increase access to low-cost hepatitis B diagnostics and generic treatment through international advocacy, private-public partnerships and patent licensing agreements.</p>
  </list-item>
  <list-item id="o0105">
   <label>6.</label>
   <p id="p0380">Strengthen health systems and integrate activities into existing health programmes such as antenatal screening, HIV and tuberculosis programmes to strengthen infrastructure, improve coordination and optimize resource allocation.</p>
  </list-item>
  <list-item id="o0110">
   <label>7.</label>
   <p id="p0385">Catalyse international investment in research and drug development to deliver hepatitis B cure.</p>
  </list-item>
 </list>
</p>
